Adma Biologics Company Profile (NASDAQ:ADMA)

About Adma Biologics

Adma Biologics logoADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADMA
  • CUSIP:
Key Metrics:
  • Previous Close: $7.32
  • 50 Day Moving Average: $6.06
  • 200 Day Moving Average: $6.65
  • 52-Week Range: $4.15 - $9.85
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.08
  • P/E Growth: 0.00
  • Market Cap: $94.20M
  • Outstanding Shares: 12,886,000
  • Beta: 2.87
Profitability:
  • Net Margins: -231.85%
  • Return on Equity: -1,293.57%
  • Return on Assets: -78.91%
Debt:
  • Debt-to-Equity Ratio: 4.62%
  • Current Ratio: 5.81%
  • Quick Ratio: 4.98%
Additional Links:
Companies Related to Adma Biologics:

Analyst Ratings

Consensus Ratings for Adma Biologics (NASDAQ:ADMA) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $14.00 (93.37% upside)

Analysts' Ratings History for Adma Biologics (NASDAQ:ADMA)
Show:
DateFirmActionRatingPrice TargetDetails
8/1/2016Raymond James Financial Inc.DowngradeStrong-Buy -> Market PerformView Rating Details
8/1/2016Maxim GroupDowngradeBuy -> HoldView Rating Details
12/8/2014Oppenheimer Holdings Inc.Initiated CoverageOutperform$20.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for Adma Biologics (NASDAQ:ADMA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/12/2016Q2($0.39)($0.50)ViewN/AView Earnings Details
5/13/2016Q1($0.37)($0.43)ViewN/AView Earnings Details
3/23/2016Q415($0.47)($0.58)$30.00 millionViewN/AView Earnings Details
11/10/2015Q315($0.39)($0.48)$1.50 million$1.85 millionViewN/AView Earnings Details
8/11/2015Q215($0.36)($0.44)$1.50 million$1.30 millionViewN/AView Earnings Details
5/12/2015Q115($0.38)($0.37)$1.50 million$1.50 millionViewN/AView Earnings Details
3/9/2015($0.38)($0.38)ViewN/AView Earnings Details
11/10/2014($0.37)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Adma Biologics (NASDAQ:ADMA)
Current Year EPS Consensus Estimate: $-1.76 EPS
Next Year EPS Consensus Estimate: $-1.19 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.37)($0.37)($0.37)
Q3 20161($0.38)($0.38)($0.38)
Q4 20161($0.38)($0.38)($0.38)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Adma Biologics (NASDAQ:ADMA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Adma Biologics (NASDAQ:ADMA)
Insider Ownership Percentage: 60.44%
Institutional Ownership Percentage: 73.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/3/2016Adam S GrossmanCEOBuy200,000$6.50$1,300,000.00View SEC Filing  
5/3/2016Brian LenzCFOBuy2,500$6.50$16,250.00View SEC Filing  
5/3/2016James MondCMOBuy770$6.50$5,005.00View SEC Filing  
5/3/2016Jerrold B GrossmanDirectorBuy45,769$6.50$297,498.50View SEC Filing  
12/8/2015Adam S. GrossmanCEOBuy500$9.00$4,500.00View SEC Filing  
12/7/2015Jerrold B GrossmanDirectorBuy500$9.01$4,505.00View SEC Filing  
12/2/2015Adam S GrossmanCEOBuy2,250$9.15$20,587.50View SEC Filing  
12/2/2015Brian LenzCFOBuy1,000$9.15$9,150.00View SEC Filing  
12/2/2015Jerrold B GrossmanDirectorBuy6,000$9.16$54,960.00View SEC Filing  
12/1/2015Adam S GrossmanCEOBuy1,800$9.17$16,506.00View SEC Filing  
11/25/2015Adam S GrossmanCEOBuy1,800$9.18$16,524.00View SEC Filing  
11/20/2015Adam S GrossmanCEOBuy3,861$9.21$35,559.81View SEC Filing  
3/19/2015Adam S GrossmanCEOBuy2,000$8.50$17,000.00View SEC Filing  
3/17/2015Adam S GrossmanCEOBuy5,500$7.98$43,890.00View SEC Filing  
3/17/2015Jerrold B GrossmanDirectorBuy500$8.01$4,005.00View SEC Filing  
3/16/2015Adam S GrossmanCEOBuy8,800$8.03$70,664.00View SEC Filing  
3/16/2015James MondCMOBuy1,250$8.02$10,025.00View SEC Filing  
3/16/2015Lawrence P GuiheenDirectorBuy1,000$7.96$7,960.00View SEC Filing  
3/13/2015Eric I RichmanDirectorBuy3,500$7.88$27,580.00View SEC Filing  
9/12/2014Adam S GrossmanCEOBuy4,300$9.57$41,151.00View SEC Filing  
8/22/2014Adam S GrossmanCEOBuy1,000$9.50$9,500.00View SEC Filing  
8/14/2014Adam S GrossmanCEOBuy2,100$9.77$20,517.00View SEC Filing  
6/18/2014Adam S GrossmanCEOBuy1,875$9.59$17,981.25View SEC Filing  
5/22/2014Adam S GrossmanCEOBuy4,226$8.15$34,441.90View SEC Filing  
5/15/2014Adam S GrossmanCEOBuy13,400$7.50$100,500.00View SEC Filing  
5/14/2014Brian LenzCFOBuy1,000$7.50$7,500.00View SEC Filing  
5/14/2014James MondCMOBuy1,315$7.60$9,994.00View SEC Filing  
12/10/2013Jerrold B GrossmanDirectorBuy3,650$7.30$26,645.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Adma Biologics (NASDAQ:ADMA)
DateHeadline
benzinga.com logoGalectin Shares Downgraded As NASH-FX Failure Likely Degrades The Prognosis For NASH-CX (NASDAQ:ADMA)
www.benzinga.com - September 30 at 3:44 PM
capitalcube.com logoETF’s with exposure to ADMA Biologics, Inc. : September 21, 2016 (NASDAQ:ADMA)
www.capitalcube.com - September 21 at 10:50 AM
biz.yahoo.com logoADMA BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ADMA)
biz.yahoo.com - September 10 at 8:04 AM
News IconPacira Pharmaceuticals, Inc. to Present at the Morgan Stanley Global ... (NASDAQ:ADMA)
www.econotimes.com - September 2 at 5:28 AM
finance.yahoo.com logoADMA Biologics to Present at Upcoming Investor Conferences (NASDAQ:ADMA)
finance.yahoo.com - September 1 at 11:45 AM
News IconInvestor News: ADMA Biologics Inc (NASDAQ:ADMA) under Investigation over possible Wrongdoing (NASDAQ:ADMA)
www.groundreport.com - August 22 at 8:06 AM
finance.yahoo.com logoADMA BIOLOGICS, INC. Financials (NASDAQ:ADMA)
finance.yahoo.com - August 19 at 3:34 PM
sbwire.com logoInvestor Investigation over Potential Wrongdoing at ADMA Biologics Inc Announced (NASDAQ:ADMA)
www.sbwire.com - August 17 at 3:20 PM
4-traders.com logoADMA Biologics : Investor Investigation over Potential Wrongdoing at ADMA Biologics Inc Announced (NASDAQ:ADMA)
www.4-traders.com - August 17 at 3:20 PM
finance.yahoo.com logoADMA - Reviewing 2Q:16 Results; Waiting for Clarity on Resubmission Timeline (NASDAQ:ADMA)
finance.yahoo.com - August 17 at 3:20 PM
capitalcube.com logoADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (NASDAQ:ADMA)
www.capitalcube.com - August 16 at 11:55 AM
reuters.com logoBRIEF-ADMA Biologics reports second quarter 2016 results (NASDAQ:ADMA)
www.reuters.com - August 13 at 11:16 AM
nasdaq.com logoADMA Biologics Reports Second Quarter 2016 Results (NASDAQ:ADMA)
www.nasdaq.com - August 13 at 11:16 AM
sg.finance.yahoo.com logoAdma Biologics reports 2Q loss (NASDAQ:ADMA)
sg.finance.yahoo.com - August 12 at 8:40 PM
biz.yahoo.com logoADMA BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ADMA)
biz.yahoo.com - August 4 at 9:01 PM
finance.yahoo.com logoADMA CRL Isolated to Partner Manufacturing Issues: Anticipate 8 Month Delay (NASDAQ:ADMA)
finance.yahoo.com - August 2 at 3:18 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ADMA Biologics, Inc. (ADMA) (NASDAQ:ADMA)
finance.yahoo.com - August 2 at 8:04 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of ADMA Biologics, Inc. (NASDAQ:ADMA)
finance.yahoo.com - August 2 at 8:04 AM
finance.yahoo.com logoINVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against ADMA Biologics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:ADMA)
finance.yahoo.com - August 2 at 8:04 AM
finance.yahoo.com logoADMA Biologics downgraded by Maxim Group (NASDAQ:ADMA)
finance.yahoo.com - August 1 at 3:18 PM
marketwatch.com logoADMA Biologics tanks 21% as Raymond James downgrades stock (NASDAQ:ADMA)
www.marketwatch.com - August 1 at 3:18 PM
insidermonkey.com logoADMA Biologics Inc (ADMA) Just Gave Us A CRL Opportunity (NASDAQ:ADMA)
www.insidermonkey.com - August 1 at 3:18 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA (NASDAQ:ADMA)
finance.yahoo.com - August 1 at 3:18 PM
rttnews.com logoTKAI Laying Off Staff Big Time, MCRB Plunges, FDA Says No To ADMA (NASDAQ:ADMA)
www.rttnews.com - August 1 at 8:05 AM
finance.yahoo.com logo4:47 pm ADMA Biologics receives CRL from the FDA over the Biologics License Application for RI-002 for the treatment of patients with Primary Humoral Immunodeficiency Disease (NASDAQ:ADMA)
finance.yahoo.com - July 31 at 4:47 PM
finance.yahoo.com logoADMA Biologics Receives Complete Response Letter from FDA for Pending Biologics License Application (NASDAQ:ADMA)
finance.yahoo.com - July 29 at 7:14 PM
breakingfinancenews.com logoA report released today by Maxim Group about ADMA Biologics Inc(NASDAQ:ADMA) drops the target price to $14 (NASDAQ:ADMA)
breakingfinancenews.com - July 25 at 3:18 PM
capitalcube.com logoETF’s with exposure to ADMA Biologics, Inc. : July 20, 2016 (NASDAQ:ADMA)
www.capitalcube.com - July 20 at 12:05 PM
4-traders.com logoADMA Biologics : to Present at the 2016 JMP Securities Life Sciences Conference (NASDAQ:ADMA)
www.4-traders.com - June 17 at 3:18 PM
finance.yahoo.com logoADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference (NASDAQ:ADMA)
finance.yahoo.com - June 16 at 7:38 AM
biz.yahoo.com logoADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o (NASDAQ:ADMA)
biz.yahoo.com - June 10 at 5:02 PM
News Icon7 North Jersey entrepreneurs named to EY annual list (NASDAQ:ADMA)
www.northjersey.com - June 2 at 11:56 AM
marketwired.com logoStayinFront Life Sciences Mobile Cloud Solution Selected by ADMA Biologics as Part of Ongoing Commercialization Infrastructure Buildout (NASDAQ:ADMA)
www.marketwired.com - June 2 at 11:56 AM
capitalcube.com logoADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 (NASDAQ:ADMA)
www.capitalcube.com - June 1 at 2:35 PM
News IconPerformance at a Glance on ADMA Biologics, Inc. (NASDAQ:ADMA) - HNN (NASDAQ:ADMA)
hintsnewsnetwork.com - May 30 at 6:34 PM
realistinvestor.com logoADMA Biologics Inc (NASDAQ:ADMA) Impact Score At 0 - RealistInvestor.com (NASDAQ:ADMA)
www.realistinvestor.com - May 30 at 6:34 PM
News IconADMA BIOLOGICS (NASDAQ:ADMA) Institutional Investor Sentiment - Wall Street Hints and News (NASDAQ:ADMA)
hintsnewsnetwork.com - May 25 at 2:49 PM
News IconTarget Check and Stock Performance Recap ADMA Biologics Inc (NASDAQ:ADMA) - Wall Street Hints and News (NASDAQ:ADMA)
hintsnewsnetwork.com - May 25 at 2:49 PM
News IconEarnings Review and Stock Rundown for ADMA Biologics Inc (NASDAQ:ADMA) - Wall Street Hints and News (NASDAQ:ADMA)
hintsnewsnetwork.com - May 25 at 2:49 PM
News IconBroker Outlook For ADMA Biologics Inc (ADMA) - Share Trading News (NASDAQ:ADMA)
www.sharetrading.news - May 21 at 2:33 PM
finance.yahoo.com logoADMA: Additional Capital Raised; Plasma Center Collections Escalating (NASDAQ:ADMA)
finance.yahoo.com - May 19 at 3:00 PM
News IconShare Recap and Earnings Focus on ADMA Biologics Inc (NASDAQ:ADMA) - Wall Street Hints and News (NASDAQ:ADMA)
hintsnewsnetwork.com - May 19 at 2:34 PM
reuters.com logoBRIEF-Adma Biologics Q1 loss per share $0.43 - Reuters (NASDAQ:ADMA)
www.reuters.com - May 14 at 8:50 AM
streetinsider.com logoADMA Biologics (ADMA) Recieves $4M in Capital Through Amended Loan and Security Agreement with Oxford Finance - StreetInsider.com (NASDAQ:ADMA)
www.streetinsider.com - May 14 at 8:50 AM
streetinsider.com logoADMA Biologics (ADMA) Recieves $4M in Capital Through Amended Loan and Security Agreement with Oxford Finance (NASDAQ:ADMA)
www.streetinsider.com - May 14 at 8:50 AM
einnews.com logoFunds to be Utilized to Advance Company’s RI-002 Commercialization Efforts and Expand Plasma Center Network (NASDAQ:ADMA)
www.einnews.com - May 14 at 8:50 AM
sg.finance.yahoo.com logoAdma Biologics reports 1Q loss (NASDAQ:ADMA)
sg.finance.yahoo.com - May 13 at 5:16 PM
finance.yahoo.com logoADMA Biologics Reports First Quarter 2016 Results (NASDAQ:ADMA)
finance.yahoo.com - May 13 at 5:05 PM
finance.yahoo.com logoADMA Biologics Further Enhances Cash Position by Securing $4.0 Million in Additional Capital Through Amended Loan and Security Agreement with Oxford Finance (NASDAQ:ADMA)
finance.yahoo.com - May 13 at 4:05 PM
News IconCheck on Analyst Ratings ADMA Biologics Inc (NASDAQ:ADMA) - B.O.D.Y Confidential (NASDAQ:ADMA)
www.bodyconfidential.com - May 10 at 9:10 AM

Social

Adma Biologics (NASDAQ:ADMA) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff